Company registration number 14273360 (England and Wales)
INNODERM LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
INNODERM LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
INNODERM LTD
BALANCE SHEET
AS AT
31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,154,652
299,799
Current assets
Stocks
10,401
5,783
Debtors
5
29,949
37,750
Cash at bank and in hand
18,105
127,274
58,455
170,807
Creditors: amounts falling due within one year
6
(527,151)
(364,493)
Net current liabilities
(468,696)
(193,686)
Total assets less current liabilities
685,956
106,113
Creditors: amounts falling due after more than one year
7
(685,698)
(48,554)
Net assets
258
57,559
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
158
57,459
Total equity
258
57,559
INNODERM LTD
BALANCE SHEET (CONTINUED)
AS AT
31 AUGUST 2025
31 August 2025
- 2 -

For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 9 April 2026 and are signed on its behalf by:
Mrs N Tyurdo
Director
Company registration number 14273360 (England and Wales)
INNODERM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
1
Accounting policies
Company information

Innoderm Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Wellesley House, Duke of Wellington Avenue, Royal Arsenal, London, SE18 6SS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

These financial statements for the year ended 31 August 2025 are the first financial statements of Innoderm Ltd prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 September 2023. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Over the length of the lease
Leasehold improvements
Over the length of the lease
Plant and equipment
5 years straight line
Computers
5 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

INNODERM LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

INNODERM LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 5 -
1.11
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
11
7
INNODERM LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 6 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 September 2024
-
0
409,130
409,130
Additions
967,638
23,983
991,621
Disposals
-
0
(63,343)
(63,343)
At 31 August 2025
967,638
369,770
1,337,408
Depreciation and impairment
At 1 September 2024
-
0
109,331
109,331
Depreciation charged in the year
20,159
73,953
94,112
Eliminated in respect of disposals
-
0
(20,687)
(20,687)
At 31 August 2025
20,159
162,597
182,756
Carrying amount
At 31 August 2025
947,479
207,173
1,154,652
At 31 August 2024
-
0
299,799
299,799
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
18,862
15,934
Other debtors
11,087
21,816
29,949
37,750
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
177,433
139,643
Taxation and social security
34,689
5,406
Other creditors
315,029
219,444
527,151
364,493
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
685,698
48,554
2025-08-31 2024-09-01 false false false 09 April 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr I Tyurdo Mrs N Tyurdo 14273360 2024-09-01 2025-08-31 14273360 2025-08-31 14273360 2024-08-31 14273360 core:LandBuildings 2025-08-31 14273360 core:OtherPropertyPlantEquipment 2025-08-31 14273360 core:LandBuildings 2024-08-31 14273360 core:OtherPropertyPlantEquipment 2024-08-31 14273360 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 14273360 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 14273360 core:WithinOneYear 2025-08-31 14273360 core:WithinOneYear 2024-08-31 14273360 core:AfterOneYear 2025-08-31 14273360 core:AfterOneYear 2024-08-31 14273360 core:CurrentFinancialInstruments 2025-08-31 14273360 core:CurrentFinancialInstruments 2024-08-31 14273360 core:ShareCapital 2025-08-31 14273360 core:ShareCapital 2024-08-31 14273360 core:RetainedEarningsAccumulatedLosses 2025-08-31 14273360 core:RetainedEarningsAccumulatedLosses 2024-08-31 14273360 bus:Director2 2024-09-01 2025-08-31 14273360 core:LandBuildings core:LongLeaseholdAssets 2024-09-01 2025-08-31 14273360 core:LeaseholdImprovements 2024-09-01 2025-08-31 14273360 core:PlantMachinery 2024-09-01 2025-08-31 14273360 core:ComputerEquipment 2024-09-01 2025-08-31 14273360 2023-09-01 2024-08-31 14273360 core:LandBuildings 2024-08-31 14273360 core:OtherPropertyPlantEquipment 2024-08-31 14273360 2024-08-31 14273360 core:LandBuildings 2024-09-01 2025-08-31 14273360 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 14273360 core:Non-currentFinancialInstruments 2025-08-31 14273360 core:Non-currentFinancialInstruments 2024-08-31 14273360 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 14273360 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 14273360 bus:FRS102 2024-09-01 2025-08-31 14273360 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 14273360 bus:Director1 2024-09-01 2025-08-31 14273360 bus:FullAccounts 2024-09-01 2025-08-31 xbrli:pure xbrli:shares iso4217:GBP